Delstrigo Prices, Coupons, Copay Cards & Patient Assistance
Delstrigo (doravirine/lamivudine/tenofovir disoproxil) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
The cost for Delstrigo (100 mg-300 mg-300 mg) oral tablet is around $2,933 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Delstrigo is available as a brand name drug only, a generic version is not yet available. View generic Delstrigo availability for more details.
Delstrigo prices
Oral Tablet
100 mg-300 mg-300 mg
Delstrigo oral tablet
from $2,932.97
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $97.77 | $2,932.97 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Delstrigo Coupons, Copay Cards and Rebates
Delstrigo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Delstrigo Savings Coupon
Eligible commercially insured patients may pay as little as $0 per prescription; maximum program savings of $6,800 per patient; coupon may be redeemed once every 21 days; for additional information contact program at 877-264-2454.
- Applies to:
- Delstrigo
- Number of uses:
- Per prescription until program expires
- Expires
- December 31, 2025
Form more information phone: 877-264-2454 or Visit website
Eligible patients may receive a FREE trial supply of Delstrigo; free trial is a 30-tablet supply; for additional information contact the program at 800-672-6372.
- Applies to:
- Delstrigo
- Number of uses:
- One-time offer
- Expires
- December 31, 2025
Form more information phone: 800-672-6372 or Visit website
Patient Assistance & Copay Programs for Delstrigo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Merck Patient Assistance Program
Eligibility requirements:- Determined case by case
- At or below 400% of FPL
- Not specified
- Must be residing in the US or a US territory, and under the care of a US physician
- At Merck we realize that sometimes exceptions need to be made based on the patient's individual circumstances. Individuals who do not meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial hardship, and their income meets the program criteria. *The Enrollment Form must be mailed. Please do not fax. Call for most recent medications as the list is subject to change.
- Delstrigo (doravirine-lamivudine-tenofovir disoproxil fumarate) Tablet
More information please phone: 800-727-5400 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Delstrigo (doravirine-lamivudine-tenofovir disoproxil fumarate) Tablet
More information please phone: 866-316-7263 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Delstrigo (doravirine / lamivudine / tenofovir disoproxil)
- Check interactions
- Compare alternatives
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español